{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:48:38Z","timestamp":1788583718242,"version":"build-2803163510"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Iron deficiency (ID) is common in patients with cardiovascular disease. Up to 60% of patients with coronary artery disease and even higher percentages of patients with heart failure (HF) or pulmonary hypertension have ID. However, the evidence for an association between ID including anemia and arrhythmias, particularly atrial fibrillation (AF) is less clear. The prevalence of ID increases with the severity of cardiac and renal dysfunction and would be more common in women. Increased blood loss due to antithrombotic therapy or gastrointestinal or renal disease and insufficient dietary iron intake, reduced iron absorption secondary to low-grade inflammation associated with congestion or reduced gastric acidity may cause ID. Both anemia and ID are associated with poor clinical outcomes, each may confer risk factors independently. There is growing evidence that ID is an important therapeutic target in patients with HF with reduced ejection fraction (HFrEF), even in the absence of anemia. Intravenous ferric carboxymaltose improved symptoms, ID-related quality of life, and exercise capacity and reduced hospitalizations for worsening HF in patients with HFrEF even mildly reduced EF (&amp;lt;50%). ID is easy to treat and effective in patients with HFrEF. These patients should be investigated for possible ID. Malnutrition has also been linked to cardiovascular disease. Both selenium and iron deficiencies have been associated with worse clinical outcomes in patients with HF. And selenium deficiency was associated with new-onset AF in nonsmoking participants. Interventional studies investigating the effects of optimizing the micronutrient status in at-risk populations are needed to assess causality, especially in those with ID. These recommendations may be extended to those populations based on evidence from future clinical trials.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1573095","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T05:23:49Z","timestamp":1752211429000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Advances in iron deficiency and iron-related arrhythmias and cardiovascular diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Sung Il","family":"Im","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/eurheartj\/ehac569","article-title":"Iron deficiency and cardiovascular disease","volume":"44","author":"Savarese","year":"2023","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1177\/15648265030244S206","article-title":"Iron deficiency: global prevalence and consequences","volume":"24","author":"Stoltzfus","year":"2003","journal-title":"Food Nutr Bull"},{"key":"B3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.nut.2012.10.015","article-title":"Iron deficiency is associated with increased risk for cardiovascular disease and all-cause mortality in the elderly living in long-term care facilities","volume":"29","author":"Hsu","year":"2013","journal-title":"Nutrition"},{"key":"B4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/0118715257313681240913112017","article-title":"Iron deficiency and its relationship with chronic heart failure- A review","volume":"23","author":"Kaur","year":"2024","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"B5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2174\/1573396320666230727102042","article-title":"Iron deficiency Anemia: an updated review","volume":"20","author":"Leung","year":"2024","journal-title":"Curr Pediatr Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1017\/S1368980008002401","article-title":"Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993\u20132005","volume":"12","author":"McLean","year":"2009","journal-title":"Public Health Nutr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ajh.23598","article-title":"Evaluation and management of anemia in the elderly","volume":"89","author":"Goodnough","year":"2014","journal-title":"Am J Hematol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12872-022-02633-6","article-title":"Anemia and iron deficiency in patients with atrial fibrillation","volume":"22","author":"Hanna-Rivero","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.12669\/pjms.315.7334","article-title":"Use of iron supplements in children aged 1\u20132 years with iron deficiency anemia: a cross-sectional study","volume":"31","author":"Sezik","year":"2015","journal-title":"Pak J Med Sci"},{"key":"B11","first-page":"40","article-title":"Iron status among Australian adults: findings of a population based study in Queensland, Australia","volume":"17","author":"Ahmed","year":"2008","journal-title":"Asia Pac J Clin Nutr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1177\/00031348221104252","article-title":"Chronic critical illness in patients with sepsis is associated with persistent Anemia, inflammation, and impaired functional outcomes","volume":"89","author":"Carmichael","year":"2023","journal-title":"Am Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The burden of iron deficiency in heart failure: therapeutic approach","volume":"71","author":"Rocha","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2399314","DOI":"10.1080\/0886022X.2024.2399314","article-title":"Inflammatory indexes and anemia in chronic kidney disease: correlation and survival analysis of the national health and nutrition examination survey 2005\u20132018","volume":"46","author":"Fu","year":"2024","journal-title":"Renal Fail"},{"key":"B15","article-title":"Anemia of chronic kidney disease","volume-title":"StatPearls","author":"Hashmi","year":"2025"},{"key":"B16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1681\/01.asn.0000926688.20809.aa","article-title":"Hepcidin-The culprit explaining disturbed iron homeostasis in chronic renal disease?: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271\u20131276, 2004","volume":"16","author":"Nemeth","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/jir.1998.18.555","article-title":"Proinflammatory cytokines lowering erythropoietin production","volume":"18","author":"Jelkmann","year":"1998","journal-title":"J Interferon Cytokine Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0158599","DOI":"10.1371\/journal.pone.0158599","article-title":"Intravenous iron carboxymaltose as a potential therapeutic in Anemia of inflammation","volume":"11","author":"Lofruthe","year":"2016","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ejhf.236","article-title":"Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?","volume":"17","author":"McDonagh","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"B21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/JHQ.0000000000000432","article-title":"Iron deficiency among hospitalized patients with congestive heart failure","volume":"46","author":"Foust","year":"2024","journal-title":"J Healthcare Quality"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.36740\/WLek\/195167","article-title":"Iron deficiency and heart failure with preserved ejection fraction","volume":"77","author":"Ternushchak","year":"2024","journal-title":"Wiad Lek"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","article-title":"Iron deficiency in heart failure: an overview","volume":"7","author":"von Haehling","year":"2019","journal-title":"JACC Heart Fail"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2024.12.045","article-title":"Atrial fibrillation ablation in heart failure: difference in 3-year outcomes between reduced and preserved ejection fraction","author":"Tan","year":"2025","journal-title":"Heart Rhythm"},{"key":"B27","doi-asserted-by":"publisher","first-page":"862164","DOI":"10.3389\/fphys.2022.862164","article-title":"Role of inflammation in the pathogenesis of atrial fibrillation","volume":"13","author":"Ihara","year":"2022","journal-title":"Front Physiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e015343","DOI":"10.1161\/JAHA.119.015343","article-title":"Characterization, pathogenesis, and clinical implications of inflammation-related atrial myopathy as an important cause of atrial fibrillation","volume":"9","author":"Packer","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B29","doi-asserted-by":"publisher","first-page":"14991","DOI":"10.1074\/jbc.RA119.009578","article-title":"A genetic mouse model of severe iron deficiency anemia reveals tissue-specific transcriptional stress responses and cardiac remodeling","volume":"294","author":"Schwartz","year":"2019","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.amjcard.2021.06.045","article-title":"Burden of mild (<13\u2005g\/dl) Anemia in patients with atrial fibrillation (A report from a multicenter registry with patient-reported outcomes)","volume":"57","author":"Hashimoto","year":"2021","journal-title":"Am J Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"101001","DOI":"10.1016\/j.cpcardiol.2021.101001","article-title":"Trends and inpatient outcomes of primary atrial fibrillation hospitalizations with underlying iron deficiency Anemia: an analysis of the national inpatient sample database from 2004 to 2018","volume":"47","author":"Minhas","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/clc.23764","article-title":"Associations of anemia with death and major bleeding in patients with atrial fibrillation: a report from the Chinese atrial fibrillation registry study","volume":"45","author":"Zhang","year":"2022","journal-title":"Clin Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e004700","DOI":"10.1136\/bmjopen-2013-004700","article-title":"Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry","volume":"4","author":"Puurunen","year":"2014","journal-title":"BMJ Open"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1093\/eurheartj\/ehz155","article-title":"Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study","volume":"40","author":"Bonde","year":"2019","journal-title":"Eur Heart J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ahj.2016.12.008","article-title":"Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial","volume":"185","author":"Westenbrink","year":"2017","journal-title":"Am Heart J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/jce.14898","article-title":"Associations of anemia with stroke, bleeding, and mortality in atrial fibrillation: a systematic review and meta-analysis","volume":"32","author":"Tu","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/jth.12874","article-title":"Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial","volume":"13","author":"Westenbrink","year":"2015","journal-title":"J Thromb Haemostasis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/clc.23559","article-title":"Impact of anemia on clinical outcomes of patients with atrial fibrillation: the COOL-AF registry","volume":"44","author":"Krittayaphong","year":"2021","journal-title":"Clin Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"100507","DOI":"10.1016\/j.ijcha.2020.100507","article-title":"Clinical relationship between anemia and atrial fibrillation recurrence after catheter ablation without genetic background","volume":"27","author":"Kim","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"B40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/ehjqcco\/qcy033","article-title":"Causes of death in Japanese patients with atrial fibrillation: the fushimi atrial fibrillation registry","volume":"5","author":"An","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/eurheartj\/ehp116","article-title":"Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial","volume":"30","author":"Anker","year":"2009","journal-title":"Eur Heart J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5543\/tkda.2018.51001","article-title":"Iron deficiency and hematinic deficiencies in atrial fibrillation: a new insight into comorbidities","volume":"46","author":"Keskin","year":"2018","journal-title":"Turk Kardiyol Dern Ars"},{"key":"B43","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2169\/internalmedicine.9554-17","article-title":"Iron deficiency Anemia due to the long-term use of a proton pump inhibitor","volume":"57","author":"Imai","year":"2018","journal-title":"Intern Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/ehf2.14276","article-title":"Iron therapy and severe arrhythmias in HFrEF: rationale, study design, and baseline results of the RESAFE-HF trial","volume":"10","author":"Bakogiannis","year":"2023","journal-title":"ESC Heart Fail"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00392-021-01837-8","article-title":"Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials","volume":"110","author":"Graham","year":"2021","journal-title":"Clin Res Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1573095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T05:23:50Z","timestamp":1752211430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1573095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":45,"alternative-id":["10.3389\/fcvm.2025.1573095"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1573095","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"article-number":"1573095"}}